BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. [electronic resource]
Producer: 20130905Description: 329-41 p. digitalISSN:- 1875-9777
- Apoptosis -- drug effects
- Humans
- Indoles
- Leukemia, Myeloid, Acute -- metabolism
- Neoplastic Stem Cells -- cytology
- Oxidative Phosphorylation -- drug effects
- Proto-Oncogene Proteins c-bcl-2 -- antagonists & inhibitors
- Pyrroles -- pharmacology
- Reactive Oxygen Species -- metabolism
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.